Stage 3 breast cancer - 10 things to know with detail
- 1. Stage 3 breast cancer is an advanced stage of breast cancer where the cancer has spread beyond the breast and nearby lymph nodes to other parts of the body.
- 2. Stage 3 breast cancer is divided into three subcategories: 3A, 3B, and 3C, based on the size of the tumor and the extent of spread to lymph nodes.
- 3. Treatment for stage 3 breast cancer typically involves a combination of surgery, radiation therapy, chemotherapy, and hormone therapy. Targeted therapy and immunotherapy may also be used in some cases.
- 4. The prognosis for stage 3 breast cancer varies depending on factors such as the size and location of the tumor, the number of lymph nodes affected, and the presence of hormone receptors. Overall, the five-year survival rate for stage 3 breast cancer is around 72%.
- 5. Common symptoms of stage 3 breast cancer may include a lump or thickening in the breast or armpit, changes in the size or shape of the breast, nipple discharge, or skin changes such as redness, dimpling, or puckering.
- 6. Risk factors for developing stage 3 breast cancer include age, family history of breast cancer, genetic mutations such as BRCA1 and BRCA2, dense breast tissue, hormone replacement therapy, and radiation exposure.
- 7. Regular mammograms and clinical breast exams can help detect breast cancer at an early stage when it is more treatable. Women with a higher risk of breast cancer may benefit from additional screening tests such as MRI or ultrasound.
- 8. Supportive care and counseling are important aspects of managing stage 3 breast cancer. Support groups, counseling, and complementary therapies can help patients cope with the physical and emotional challenges of cancer treatment.
- 9. Lifestyle changes such as maintaining a healthy weight, exercising regularly, eating a balanced diet, limiting alcohol intake, and avoiding tobacco can help reduce the risk of breast cancer and improve overall health.
- 10. Research into new treatments and therapies for stage 3 breast cancer is ongoing. Clinical trials offer patients access to cutting-edge treatments and the opportunity to contribute to advancements in cancer care.